Investing Profile

Raphael Wisniewski

InvestorVC
Associate at Andera Partners
anderapartners.com/en/team/ra...Paris, France
Photo of Raphael Wisniewski, Associate at Andera Partners
Your Intro Paths to Raphael Wisniewski

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Raphael Wisniewski on

cb
Current Investing Position
Andera Partners Associate
Investment Range
$5.0M - $35.0M
Sweet Spot
$20.0M
Investments On Record
16

Raphael Wisniewski is on these Sector & Stage Rankings

Raphael Wisniewski's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
ENYO Pharma
Series CJan 2024$43M
Series BJun 2018$47M
$90M
Co-investors: Carl Gordon (OrbiMed), Iain Dukes (OrbiMed)
BioVentrix
Series AApr 2023$49M
$49M
Andera Partners
Series AApr 2023$49M
$49M
SoniVie
Series CJan 2023$60M
$60M
Amolyt Pharma
Series CJan 2023$140M
$290M
Co-investors: Felice Verduyn - van Weegen (EQT Life Sciences), Iyona Rajkomar (Pontifax Venture Capital), Cedric Moreau (Soffinova Partners), Thierry Laugel (Kurma Partners), Ohad Hammer (Pontifax Venture Capital)
ImCheck Therapeutics
Series CJun 2022$100M
$180M
Co-investors: Michael Baran (Pfizer Venture Investments), Rémi Droller (Kurma Partners), Dr. Regina Hodits (Wellington Partners), Klaus Breiner (Pureos Bioventures), Florent Gros (Earlybird Venture Capital), Vincent Brichard
Exciva
Series AOct 2021$10M
$10M
Co-investors: Sofia Ioannidou (Andera Partners)
Artios Pharma
Series CJul 2021$150M
Series BAug 2018$83M
$270M
Co-investors: Hakan Goker (M Ventures (Merck)), René Kuijten (EQT Life Sciences), Florian Müllershausen (Novartis Venture Fund), Barbara Dalton (Pfizer Venture Investments)